Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A

BACKGROUND: Gene therapy provides a novel method for the prevention and treatment of cancer, but the clinical application of gene therapy is restricted, mainly because of the absence of an efficient and safe gene delivery system. Recently, we developed a novel nonviral gene carrier, ie, heparin-poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ling, Gao, Xiang, Men, Ke, Wang, BiLan, Zhang, Shuang, Qiu, Jinfeng, Huang, Meijuan, Gou, MaLing, Huang, Ning, Qian, ZhiYong, Zhao, Xia, Wei, YuQuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205136/
https://www.ncbi.nlm.nih.gov/pubmed/22072877
http://dx.doi.org/10.2147/IJN.S23582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205136/
https://www.ncbi.nlm.nih.gov/pubmed/22072877
http://dx.doi.org/10.2147/IJN.S23582

Ejemplares similares